"Closer Look" Series Examines Hot Topics in Corporate Governance

Case studies explore governance challenges at top companies and myths surrounding board practices.

July 01, 2011

As investors and regulators take a heightened interest in the role of boards, researchers at Stanford GSB are examining today’s most hotly debated topics in corporate governance. In Stanford’s “Closer Look” case study series, launched by the school’s Corporate Governance Research Program, faculty member David Larcker and researcher Brian Tayan take on everything from the sudden resignation of David Sokol from Berkshire Hathaway to the obligation of boards to disclose CEO health concerns to the (questionable) real value of proxy access.

“We launched the Closer Look series to give directors and board observers a deeper dive into some of the most important issues that boards are dealing with today,” says Larcker, who is James Irvin Miller Professor of Accounting and director of the Corporate Governance Research Program. “Rather than rehash the standard ‘best practice’ governance advice for boards, we look at these issues in real time, based on the real trade-offs that companies have to make in complicated settings.”

With new releases once a month, the Closer Look series has explored the following topics, among others:

“The Closer Looks present a snapshot of our extensive research into timely governance issues, and show how theory plays out in practice,” says Tayan, researcher with the Corporate Governance Research Program. He and Larcker are authors of the new book, Corporate Governance Matters.

For media inquiries, visit the Newsroom.

Explore More

May 09, 2024
Written

Stanford GSB Professor Neil Malhotra Named Carnegie Fellow

Award will fund continuing research on political polarization
May 09, 2024
Written

Stanford GSB Researchers Discuss the Ideas They’re Most Excited About

If you’re looking for smart answers to complex questions, then you should check out this new podcast.
May 02, 2024
Written

Room to Grow: The Cannabis Industry Can’t Wait to Go Mainstream

No longer illicit, but not fully legit, the market for legal marijuana is anticipating big changes — soon?